Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1120689 | 0.99 | CNR2 (0.31) | CNR2NPC1MAPTRAB9ASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL818624 | 0.85 | HTR7 (0.31) | — | |
| Hydrochloric Acid SCHEMBL1120673 | 0.83 | HTR7 (0.32) | CNR2CNR1 | |
| SCHEMBL5890628 | 0.82 | NPC1 (0.31) | NPC1MAPTRAB9ASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL3697570 | 0.81 | CNR1 (0.34) | CNR2CNR1 | |
| SCHEMBL1583128 | 0.81 | ALOX5 (0.39) | CNR2NPC1MAPTRAB9ASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL7935519 | 0.81 | NPC1 (0.32) | NPC1MAPTRAB9ASMN1; SMN2ALOX5 | |
| SCHEMBL8204449 | 0.80 | KDM4E (0.33) | MAPTPTPN1 | |
| SCHEMBL3696397 | 0.80 | PTPN1 (0.33) | NPC1MAPTRAB9ASMN1; SMN2ALOX5 | |
| Hydrochloric Acid SCHEMBL27476742 | 0.79 | NPC1 (0.33) | CNR2NPC1MAPTRAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2114567-B1 | IRON COMPLEXES AND THEIR USE IN POLYMERIZATION PROCESSES | BASELL POLYOLEFINE GMBH (DE) | 2015-04-15 | — | — | EP | disclosed |
| US-8227557-B2 | Iron complexes and their use in polymerization processes | BASELL POLYOLEFINE GMBH (DE) | 2012-07-24 | — | — | US | disclosed |
| US-20100087607-A1 | IRON COMPLEXES AND THEIR USE IN POLYMERIZATION PROCESSES | BASELL POLYOLEFINE GMBH (DE) | 2010-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087607-A1 | IRON COMPLEXES AND THEIR USE IN POLYMERIZATION PROCESSES | PPOX, TFRC, FECH | CNR2 3486/4885NPC1 3072/4885MAPT 2570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.